BR0009083B1 - derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida. - Google Patents

derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida.

Info

Publication number: BR0009083B1
Authority: BR; Brazil
Prior art keywords: amide derivative; preparation; pharmaceutical composition; quinazolinone; nucleus
Prior art date: 1999-03-17

Application number

BRPI0009083-2A

Other languages

English (en)

Other versions

BR0009083A (pt

Inventor

Dearg Sutherland Brown

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-17

Filing date

2000-03-13

Publication date

2011-11-01

1999-03-17 Priority claimed from GBGB9906279.6A external-priority patent/GB9906279D0/en

1999-11-11 Priority claimed from GBGB9926667.8A external-priority patent/GB9926667D0/en

2000-03-13 Application filed filed Critical

2002-01-02 Publication of BR0009083A publication Critical patent/BR0009083A/pt

2011-11-01 Publication of BR0009083B1 publication Critical patent/BR0009083B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Immunology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Tropical Medicine & Parasitology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Hydrogenated Pyridines (AREA)

BRPI0009083-2A 1999-03-17 2000-03-13 derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida. BR0009083B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9906279.6A GB9906279D0 (en)	1999-03-17	1999-03-17	Amide derivatives
GBGB9926667.8A GB9926667D0 (en)	1999-11-11	1999-11-11	Amide derivatives
PCT/GB2000/000912 WO2000055153A1 (en)	1999-03-17	2000-03-13	Amide derivatives

Publications (2)

Publication Number	Publication Date
BR0009083A BR0009083A (pt)	2002-01-02
BR0009083B1 true BR0009083B1 (pt)	2011-11-01

Family

ID=26315301

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0009083-2A BR0009083B1 (pt)	1999-03-17	2000-03-13	derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida.

Country Status (28)

Country	Link
US (3)	US7008945B1 (pt)
EP (1)	EP1163237B1 (pt)
JP (1)	JP4619545B2 (pt)
KR (1)	KR100757282B1 (pt)
CN (1)	CN1178932C (pt)
AR (1)	AR028988A1 (pt)
AT (1)	ATE266023T1 (pt)
AU (1)	AU761453B2 (pt)
BR (1)	BR0009083B1 (pt)
CA (1)	CA2368097C (pt)
CZ (1)	CZ300293B6 (pt)
DE (1)	DE60010448T2 (pt)
DK (1)	DK1163237T3 (pt)
ES (1)	ES2219319T3 (pt)
HK (1)	HK1041885A1 (pt)
HU (1)	HUP0105114A3 (pt)
IL (2)	IL145357A0 (pt)
MX (1)	MXPA01009307A (pt)
MY (1)	MY128501A (pt)
NO (1)	NO323191B1 (pt)
NZ (1)	NZ514195A (pt)
PL (1)	PL200804B1 (pt)
PT (1)	PT1163237E (pt)
RU (1)	RU2260007C2 (pt)
SK (1)	SK287238B6 (pt)
TR (1)	TR200103336T2 (pt)
TW (1)	TWI247745B (pt)
WO (1)	WO2000055153A1 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7772432B2 (en)	1991-09-19	2010-08-10	Astrazeneca Ab	Amidobenzamide derivatives which are useful as cytokine inhibitors
GB9816837D0 (en)	1998-08-04	1998-09-30	Zeneca Ltd	Amide derivatives
PT1017378E (pt)	1997-09-23	2003-04-30	Astrazeneca Ab	Derivados de amida para o tratamento de doencas mediadas por citoquinas
ID26236A (id)	1998-05-15	2000-12-07	Astrazeneca Ab	Turunan benzamida untuk pengobatan penyakit yang diperantarai oleh sitokina
DE69921804T2 (de)	1998-05-15	2005-10-27	Astrazeneca Ab	Benzamid-derivate zur behandlung cytokin-vermittelter krankheiten
PL345817A1 (en)	1998-08-04	2002-01-14	Astrazeneca Ab	Amide derivatives useful as inhibitors of the production of cytokines
BR9913947A (pt)	1998-09-25	2001-06-12	Astrazeneca Ab	Derivado de amida, processo para a preparação do mesmo ou um sal farmaceuticamente aceitável ou éster clivável in vivo deste, uso do mesmo, e, composição farmacêutica
BR0009041A (pt)	1999-03-17	2001-12-26	Astrazeneca Ab	Derivado de amida, processo para a preparação deum derivado de amida, composição farmacêutica,uso de um derivado de amida, e, método paratratar doenças ou quadros clìnicos mediados porcitocinas
MXPA01009307A (es) *	1999-03-17	2002-07-30	Astrazeneca Ab	Derivados de amida.
GB9906566D0 (en)	1999-03-23	1999-05-19	Zeneca Ltd	Chemical compounds
GB9924092D0 (en)	1999-10-13	1999-12-15	Zeneca Ltd	Pyrimidine derivatives
DE10155075A1 (de) *	2001-11-09	2003-05-22	Merck Patent Gmbh	Cyclische Sulfonamide
ATE349210T1 (de)	2002-07-09	2007-01-15	Boehringer Ingelheim Pharma	Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
GEP20084540B (en)	2003-01-14	2008-11-25	Arena Pharm Inc	1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
GB0324790D0 (en) *	2003-10-24	2003-11-26	Astrazeneca Ab	Amide derivatives
CA2568756A1 (en) *	2004-06-15	2005-12-29	Astrazeneca Ab	Substituted quinazolones as anti-cancer agents
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
MY140868A (en) *	2004-12-24	2010-01-29	Astrazeneca Ab	Amide derivatives
GB0504019D0 (en) *	2005-02-26	2005-04-06	Astrazeneca Ab	Amide derivatives
CN102603581B (zh) *	2005-06-22	2015-06-24	普莱希科公司	作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
GB0516570D0 (en) *	2005-08-12	2005-09-21	Astrazeneca Ab	Amide derivatives
CN101506171A (zh) *	2006-06-19	2009-08-12	阿斯利康(瑞典)有限公司	作为细胞因子介导的疾病的抑制剂的异喹啉衍生物及其用途
US7834023B2 (en)	2006-09-20	2010-11-16	Portola Pharmaceuticals, Inc.	Substituted dihydroquinazolines as platelet ADP receptor inhibitors
WO2008063888A2 (en)	2006-11-22	2008-05-29	Plexxikon, Inc.	Compounds modulating c-fms and/or c-kit activity and uses therefor
TW200845988A (en)	2007-04-05	2008-12-01	Astrazeneca Ab	New compounds and their uses 707
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
EP2170830B1 (en)	2007-07-17	2014-10-15	Plexxikon, Inc.	2-FLUORO-BENZENESULFONAMIDE COMPOUNDS AS Raf KINASE MODULATORS
US7868001B2 (en) *	2007-11-02	2011-01-11	Hutchison Medipharma Enterprises Limited	Cytokine inhibitors
AR073711A1 (es)	2008-10-01	2010-11-24	Astrazeneca Ab	Derivados de isoquinolina
US9447089B2 (en)	2009-04-03	2016-09-20	Plexxikon Inc.	Compositions and uses thereof
EA201290210A1 (ru)	2009-11-06	2012-10-30	Плексксикон, Инк.	Соединения и способы модуляции киназы и показания для их применения
EP2619198A1 (en)	2010-09-22	2013-07-31	Arena Pharmaceuticals, Inc.	Modulators of the gpr119 receptor and the treatment of disorders related thereto
EA028821B9 (ru)	2011-02-07	2018-10-31	Плексксикон, Инк.	Соединения и способы для модуляции киназ, а также показания к их применению
AR085279A1 (es)	2011-02-21	2013-09-18	Plexxikon Inc	Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9181226B2 (en) *	2011-07-18	2015-11-10	Merck Patent Gmbh	Benzamides
DE102012101680A1 (de) *	2012-02-29	2013-08-29	Aicuris Gmbh & Co. Kg	Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds
GB201317609D0 (en)	2013-10-04	2013-11-20	Cancer Rec Tech Ltd	Inhibitor compounds
JO3512B1 (ar)	2014-03-26	2020-07-05	Astex Therapeutics Ltd	مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
JP6895378B2 (ja)	2015-01-06	2021-06-30	アリーナファーマシューティカルズ，インコーポレイテッド	Ｓ１ｐ１受容体に関連する状態の処置方法
GB201505658D0 (en)	2015-04-01	2015-05-13	Cancer Rec Tech Ltd	Inhibitor compounds
AU2016284162A1 (en)	2015-06-22	2018-02-01	Arena Pharmaceuticals, Inc.	Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(Compound1) for use in SIP1 receptor-associated disorders
WO2017003723A1 (en)	2015-07-01	2017-01-05	Crinetics Pharmaceuticals, Inc.	Somatostatin modulators and uses thereof
DK3353164T3 (da)	2015-09-23	2022-01-24	Janssen Pharmaceutica Nv	Bi-heteroarylsubstituerede 1,4-benzodiazepiner og anvendelser deraf til behandling af cancer
RU2747645C2 (ru)	2015-09-23	2021-05-11	Янссен Фармацевтика Нв	Новые соединения
WO2017151409A1 (en)	2016-02-29	2017-09-08	University Of Florida Research Foundation, Incorporated	Chemotherapeutic methods
GB201617103D0 (en)	2016-10-07	2016-11-23	Cancer Research Technology Limited	Compound
AU2018220521A1 (en)	2017-02-16	2019-09-05	Arena Pharmaceuticals, Inc.	Compounds and methods for treatment of primary biliary cholangitis
EP3658560A4 (en)	2017-07-25	2021-01-06	Crinetics Pharmaceuticals, Inc.	SOMATOSTAT IN MODULATORS AND USES THEREOF
AR112840A1 (es)	2017-09-29	2019-12-18	Bayer Ag	3- fenilquinazolin-4(3h)-onas sustituidas y sus usos
WO2019063708A1 (en)	2017-09-29	2019-04-04	Bayer Aktiengesellschaft	SUBSTITUTED 3-PHENYLQUINAZOLIN-4 (3H) -ONES AND USES THEREOF
WO2019236757A1 (en)	2018-06-06	2019-12-12	Arena Pharmaceuticals, Inc.	Methods of treating conditions related to the s1p1 receptor
UA126619C2 (uk)	2018-10-31	2022-11-02	Гіліад Сайєнсіз, Інк.	Заміщені сполуки 6-азабензімідазолу як інгібітори hpk1
AU2019373221B2 (en)	2018-10-31	2022-05-26	Gilead Sciences, Inc.	Substituted 6-azabenzimidazole compounds having HPK1 inhibitory activity
EP3972695A1 (en)	2019-05-23	2022-03-30	Gilead Sciences, Inc.	Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
IL297137A (en) *	2020-04-08	2022-12-01	Remix Therapeutics Inc	Splicing Modulation Compounds and Methods

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1903899A (en)		1933-04-18		Cabboxylic acid abylides oe the benzene sebies and process oe making
DE522788C (de)	1928-11-01	1931-04-15	I G Farbenindustrie Akt Ges	Verfahren zur Darstellung von Carbonsaeurearyliden der Benzolreihe
US1909960A (en)	1929-08-06	1933-05-23	Du Pont	Intermediate for azo dyes
BE611898A (pt)	1960-12-23
US3755332A (en)	1971-07-01	1973-08-28	Ciba Geigy Corp	Substituted 4 indazolaminoquinolines
DE2812252A1 (de)	1978-03-21	1979-10-04	Bayer Ag	1,2,4-triazol-blockierte polyisocyanate als vernetzer fuer lackbindemittel
US4367328A (en)	1981-03-05	1983-01-04	The Dow Chemical Company	Epoxy resins from hydroxy benzamides
US4524168A (en)	1981-11-18	1985-06-18	Ciba-Geigy Corporation	Process for the mass coloration of polymers
US4749729A (en)	1984-06-21	1988-06-07	American Cyanamid Company	Epoxy resin compositions curable above 160 F. and below 250 F.
JPS61204221A (ja)	1985-03-07	1986-09-10	Hitachi Chem Co Ltd	熱硬化性樹脂組成物
US5710158A (en)	1991-05-10	1998-01-20	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
WO1993004170A1 (en)	1991-08-23	1993-03-04	The United States Of America Represented By The Secretary, Department Of Health And Human Services	Raf protein kinase therapeutics
GB9816837D0 (en)	1998-08-04	1998-09-30	Zeneca Ltd	Amide derivatives
GB9300059D0 (en)	1992-01-20	1993-03-03	Zeneca Ltd	Quinazoline derivatives
GB9314884D0 (en)	1993-07-19	1993-09-01	Zeneca Ltd	Tricyclic derivatives
IL112249A (en)	1994-01-25	2001-11-25	Warner Lambert Co	Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5550132A (en)	1994-06-22	1996-08-27	University Of North Carolina	Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
CA2228050A1 (en)	1995-08-10	1997-02-20	Harold G. Selnick	2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
CA2230082C (en)	1995-08-22	2005-07-05	Japan Tobacco Inc.	Amide compounds and use thereof
AR004010A1 (es)	1995-10-11	1998-09-30	Glaxo Group Ltd	Compuestos heterociclicos
GB9604926D0 (en)	1996-03-08	1996-05-08	Sandoz Ltd	Organic compounds
US6096748A (en)	1996-03-13	2000-08-01	Smithkline Beecham Corporation	Pyrimidine compounds useful in treating cytokine mediated diseases
JP2001506230A (ja)	1996-08-09	2001-05-15	スミスクライン・ビーチャム・コーポレイション	新規ピペラジン含有化合物
GB9623833D0 (en)	1996-11-16	1997-01-08	Zeneca Ltd	Chemical compound
AU8181098A (en)	1997-07-03	1999-01-25	Du Pont Pharmaceuticals Company	Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
ZA986732B (en)	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitiors of tyrosine kinases
PT1017378E (pt)	1997-09-23	2003-04-30	Astrazeneca Ab	Derivados de amida para o tratamento de doencas mediadas por citoquinas
ATE232521T1 (de)	1998-03-27	2003-02-15	Janssen Pharmaceutica Nv	Hiv hemmende pyrimidin derivate
ID26236A (id)	1998-05-15	2000-12-07	Astrazeneca Ab	Turunan benzamida untuk pengobatan penyakit yang diperantarai oleh sitokina
DE69921804T2 (de)	1998-05-15	2005-10-27	Astrazeneca Ab	Benzamid-derivate zur behandlung cytokin-vermittelter krankheiten
PL345817A1 (en)	1998-08-04	2002-01-14	Astrazeneca Ab	Amide derivatives useful as inhibitors of the production of cytokines
EP1110951B1 (en)	1998-08-27	2004-05-19	Sumitomo Pharmaceuticals Company, Limited	Pyrimidine derivatives
WO2000012485A1 (en)	1998-08-29	2000-03-09	Astrazeneca Ab	Pyrimidine compounds
AU5438499A (en)	1998-08-29	2000-03-21	Astrazeneca Ab	Pyrimidine compounds
BR9913947A (pt)	1998-09-25	2001-06-12	Astrazeneca Ab	Derivado de amida, processo para a preparação do mesmo ou um sal farmaceuticamente aceitável ou éster clivável in vivo deste, uso do mesmo, e, composição farmacêutica
DK1117653T3 (da)	1998-10-01	2003-05-26	Astrazeneca Ab	Quinolin- og quinazolinderivater og deres anvendelse som inhibitorer af cykokin-merierede sygdomme
BR0009041A (pt)	1999-03-17	2001-12-26	Astrazeneca Ab	Derivado de amida, processo para a preparação deum derivado de amida, composição farmacêutica,uso de um derivado de amida, e, método paratratar doenças ou quadros clìnicos mediados porcitocinas
MXPA01009307A (es)	1999-03-17	2002-07-30	Astrazeneca Ab	Derivados de amida.
GB9906566D0 (en) *	1999-03-23	1999-05-19	Zeneca Ltd	Chemical compounds
GB9924092D0 (en)	1999-10-13	1999-12-15	Zeneca Ltd	Pyrimidine derivatives
IL156304A0 (en)	2000-12-11	2004-01-04	Tularik Inc	Cxcr3 antagonists
TW200306839A (en)	2002-02-06	2003-12-01	Novartis Ag	Quinazolinone derivatives and their use as CB agonists
GB0324790D0 (en)	2003-10-24	2003-11-26	Astrazeneca Ab	Amide derivatives

2000
- 2000-03-13 MX MXPA01009307A patent/MXPA01009307A/es active IP Right Grant
- 2000-03-13 DE DE60010448T patent/DE60010448T2/de not_active Expired - Lifetime
- 2000-03-13 SK SK1311-2001A patent/SK287238B6/sk not_active IP Right Cessation
- 2000-03-13 JP JP2000605582A patent/JP4619545B2/ja not_active Expired - Fee Related
- 2000-03-13 WO PCT/GB2000/000912 patent/WO2000055153A1/en active IP Right Grant
- 2000-03-13 KR KR1020017011821A patent/KR100757282B1/ko not_active IP Right Cessation
- 2000-03-13 CN CNB008074968A patent/CN1178932C/zh not_active Expired - Fee Related
- 2000-03-13 PL PL350451A patent/PL200804B1/pl not_active IP Right Cessation
- 2000-03-13 PT PT00909498T patent/PT1163237E/pt unknown
- 2000-03-13 RU RU2001128066/04A patent/RU2260007C2/ru not_active IP Right Cessation
- 2000-03-13 EP EP00909498A patent/EP1163237B1/en not_active Expired - Lifetime
- 2000-03-13 BR BRPI0009083-2A patent/BR0009083B1/pt not_active IP Right Cessation
- 2000-03-13 US US09/936,758 patent/US7008945B1/en not_active Expired - Fee Related
- 2000-03-13 AU AU31778/00A patent/AU761453B2/en not_active Ceased
- 2000-03-13 DK DK00909498T patent/DK1163237T3/da active
- 2000-03-13 NZ NZ514195A patent/NZ514195A/en not_active IP Right Cessation
- 2000-03-13 ES ES00909498T patent/ES2219319T3/es not_active Expired - Lifetime
- 2000-03-13 CZ CZ20013319A patent/CZ300293B6/cs not_active IP Right Cessation
- 2000-03-13 IL IL14535700A patent/IL145357A0/xx active IP Right Grant
- 2000-03-13 HU HU0105114A patent/HUP0105114A3/hu unknown
- 2000-03-13 TR TR2001/03336T patent/TR200103336T2/xx unknown
- 2000-03-13 AT AT00909498T patent/ATE266023T1/de active
- 2000-03-13 CA CA002368097A patent/CA2368097C/en not_active Expired - Fee Related
- 2000-03-15 MY MYPI20001019A patent/MY128501A/en unknown
- 2000-03-16 AR ARP000101163A patent/AR028988A1/es active IP Right Grant
- 2000-03-16 TW TW089104783A patent/TWI247745B/zh not_active IP Right Cessation
2001
- 2001-09-10 IL IL145357A patent/IL145357A/en not_active IP Right Cessation
- 2001-09-14 NO NO20014492A patent/NO323191B1/no not_active IP Right Cessation
2002
- 2002-05-21 HK HK02103785A patent/HK1041885A1/xx not_active IP Right Cessation
2005
- 2005-07-08 US US11/176,327 patent/US7442704B2/en not_active Expired - Fee Related
2006
- 2006-08-18 US US11/505,904 patent/US7332483B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7442704B2 (en)	2008-10-28
KR100757282B1 (ko)	2007-09-11
ES2219319T3 (es)	2004-12-01
HK1041885A1 (en)	2002-07-26
DK1163237T3 (da)	2004-08-02
AU3177800A (en)	2000-10-04
IL145357A (en)	2007-07-24
HUP0105114A2 (hu)	2002-07-29
NZ514195A (en)	2004-05-28
IL145357A0 (en)	2002-06-30
TR200103336T2 (tr)	2002-04-22
CZ20013319A3 (cs)	2001-12-12
PL200804B1 (pl)	2009-02-27
CN1350530A (zh)	2002-05-22
US20060281734A1 (en)	2006-12-14
SK287238B6 (sk)	2010-04-07
JP2002539207A (ja)	2002-11-19
ATE266023T1 (de)	2004-05-15
TWI247745B (en)	2006-01-21
MXPA01009307A (es)	2002-07-30
AU761453B2 (en)	2003-06-05
EP1163237A1 (en)	2001-12-19
DE60010448T2 (de)	2005-04-07
AR028988A1 (es)	2003-06-04
RU2260007C2 (ru)	2005-09-10
US7332483B2 (en)	2008-02-19
HUP0105114A3 (en)	2002-09-30
NO20014492D0 (no)	2001-09-14
US7008945B1 (en)	2006-03-07
NO20014492L (no)	2001-11-12
NO323191B1 (no)	2007-01-15
SK13112001A3 (sk)	2002-06-04
KR20010113756A (ko)	2001-12-28
CA2368097A1 (en)	2000-09-21
BR0009083A (pt)	2002-01-02
US20050245551A1 (en)	2005-11-03
EP1163237B1 (en)	2004-05-06
CZ300293B6 (cs)	2009-04-15
CN1178932C (zh)	2004-12-08
PT1163237E (pt)	2004-08-31
CA2368097C (en)	2010-01-19
MY128501A (en)	2007-02-28
PL350451A1 (en)	2002-12-16
DE60010448D1 (de)	2004-06-09
JP4619545B2 (ja)	2011-01-26
WO2000055153A1 (en)	2000-09-21

Publication	Publication Date	Title
BR0009083B1 (pt)	2011-11-01	derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida.
BR9912109B1 (pt)	2012-08-21	compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto.
BR0008753B1 (pt)	2013-11-12	Composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida
BR9909995B1 (pt)	2010-07-13	composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.
BR9807814B1 (pt)	2009-01-13	composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9808422B1 (pt)	2010-08-24	composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9810829B1 (pt)	2009-08-11	composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
BR0009486B1 (pt)	2011-03-09	composto que compreende uma amida, composição farmacêutica que compreende esse composto, seu uso e processo para a preparação do mesmo.
BR9810802B1 (pt)	2010-10-19	composto, composição farmacêutica, e, processo para a preparação de um composto.
BR0008840B1 (pt)	2011-12-27	derivados de camptotecina, processos para a sua preparaÇço, composiÇço farmacÊutica que os compreende e uso dos mesmos.
BR0017030B1 (pt)	2013-10-01	derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
BR9909925B1 (pt)	2010-09-21	derivados de quinolina, composições farmacêuticas, e, processo para a fabricação de derivados de quinolina.
EE200200095A (et)	2003-04-15	Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
BR9911182B1 (pt)	2010-09-08	compostos derivados de biarila com propriedades agonistas de adrenorreceptores beta-3, uso de um composto, composição farmacêutica, e, processo para a preparação de um composto.
EE200300581A (et)	2004-02-16	Karboksamiid-asendatud fenüüluurea derivaadid ja nende kasutamine, ravim ja selle valmistamismeetod
EE04464B1 (et)	2005-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
BR9801606B1 (pt)	2010-07-27	composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
BRPI0009956B1 (pt)	2014-11-11	Composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma
EE200200017A (et)	2003-04-15	Kinuklidiinderivaadid, nende valmistamismeetod, vaheühendid, farmatseutiline kompositsioon ja nendekasutamine
EE200300327A (et)	2003-10-15	Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
BR9912104B1 (pt)	2010-07-13	compostos derivados de quinolina, composições farmacêuticas, e, processo para a manufatura de um composto.
BR9711311B1 (pt)	2009-01-13	derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
NO20016038L (no)	2002-02-11	Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
BR9906373B1 (pt)	2010-11-16	compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos.
BR9807682B1 (pt)	2009-01-13	composto, uso do mesmo, composiÇço farmacÊutica, e, processos para preparar um composto.

Legal Events

Date	Code	Title	Description
2009-09-01	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2010-02-23	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2011-02-22	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2011-11-01	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 01/11/2011, OBSERVADAS AS CONDICOES LEGAIS.
2014-04-22	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 14A ANUIDADE.
2015-11-24	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2259 DE 22-04-2014 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.